Jeffrey Eisele - Dec 22, 2021 Form 4 Insider Report for Apellis Pharmaceuticals, Inc. (APLS)

Role
Exec VP, Program Team Lead
Signature
/s/ David Watson, attorney-in-fact for Jeffrey Eisele
Stock symbol
APLS
Transactions as of
Dec 22, 2021
Transactions value $
-$4,256
Form type
4
Date filed
12/23/2021, 03:49 PM
Next filing
Jan 25, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction APLS Common Stock Tax liability -$4.26K -89 -1.19% $47.82 7.37K Dec 22, 2021 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This represents shares used to cover tax withholding on a Restricted Stock Unit release.